Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
Evaluate the immune response of GSK Biologicals\' 10-valent pneumococcal conjugate vaccine one month after completion of a 3-dose primary vaccination course administered at 2, 3, 4 months of age
Epistemonikos ID: 118c291dd64dfde9791fcdfae01aa696bb111127
First added on: Nov 24, 2021